The datasets in which POGZ showed significant aCGH/expression correlation corresponded to the following tissues and cancer pathologies: Breast (ER+, ERBB2 amplified, Inflammatory), Head and Neck Squamous Cell, Lung Adenocarcinoma, Lymphoma, Multiple Myeloma, Osteosarcoma, Ovarian, Pancreatic, Prostate and Urothelial. This evidence concerns the gene POGZ and lung adenocarcinoma.